MedTrace Logo

A Longitudinal Multidimensional Population Study on Brain Aging

NCT01345110 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1321

Last updated 2015-12-11

No results posted yet for this study

Summary

Longitudinal observational study of cognitive functions, physical health and biological parameters in the whole population living in Abbiategrasso born between 1935 and 1939,1773 subjects, followed for six years in order to know the prevalence and the incidence of dementia and risk and protective factors of normal and pathological mental aging.

The peculiarities of this study that must assure the outcome efficacy are:

* Selected age: since 70-75 years old people represents a transition age from adulthood to old age, it is of special interest to study the evolution of psychic and physical functions of this population
* Whole population not a sample study
* Location: the small area involved (Abbiategrasso is a town of 30.000 inhabitants)can contribute to guarantee more homogeneity among the subjects and reduce undesired variability
* multidimensional assessment(biological, clinical, social, psychological data collected) After initial screening, the recruited population will be followed up for two more times (every two years )

Conditions

  • Dementia
  • Alzheimer Disease
  • Vascular Dementia

Sponsors & Collaborators

  • Alzheimer Federation Italy

    collaborator OTHER

  • Mario Negri Institute for Pharmacological Research

    collaborator OTHER

  • University of Pavia

    collaborator OTHER

  • Camillo Golgi Geriatric Institute

    collaborator OTHER

  • Fondazione Golgi Cenci

    lead OTHER

Principal Investigators

  • ANTONIO GUAITA, MD · Golgi Cenci Foundation (research and study on aging)

Eligibility

Min Age
70 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01345110 on ClinicalTrials.gov